On mechanism of action of sublingual immunotherapy

Pediatric Allergy and Immunology

Volumn 20, Issue 1, 2009, Pages 102-

  Incorvaia, C ^a   Frati, F ^b,c  

^a ICP Hospital   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Medical and Scientific Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 32; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ALLERGY; CLONAL ANERGY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DOSAGE FORM COMPARISON; DRUG MECHANISM; HUMAN; IMMUNOTHERAPY; LETTER; MITE; MITE ALLERGY; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, SUBLINGUAL; ANIMALS; CHILD; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; PYROGLYPHIDAE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 58449111522     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2008.00825.x     Document Type: Letter

References (4)

1. Antunez C, Mayorga C, Corzo JL, Jurado A, Torres MJ. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol 2008 : 19 : 210 8.
2. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007 : 119 : 780 91.
3. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10 producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007 : 120 : 707 13.
4. Novak N, Haberstok K, Bieber T, Allam JP. The immune privilege of the oral mucosa. Trends Mol Med 2008 : 14 : 191 8.